DK1034174T3 - Azaringetherderivater og disses anvendelse som nikotin-ACh-receptormodulatorer - Google Patents
Azaringetherderivater og disses anvendelse som nikotin-ACh-receptormodulatorerInfo
- Publication number
- DK1034174T3 DK1034174T3 DK98952578T DK98952578T DK1034174T3 DK 1034174 T3 DK1034174 T3 DK 1034174T3 DK 98952578 T DK98952578 T DK 98952578T DK 98952578 T DK98952578 T DK 98952578T DK 1034174 T3 DK1034174 T3 DK 1034174T3
- Authority
- DK
- Denmark
- Prior art keywords
- azaring
- heterocyclic group
- ach receptor
- receptor modulators
- ether derivatives
- Prior art date
Links
- 108010009685 Cholinergic Receptors Proteins 0.000 title abstract 2
- 102000034337 acetylcholine receptors Human genes 0.000 title abstract 2
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 title 1
- 150000002170 ethers Chemical class 0.000 title 1
- 229960002715 nicotine Drugs 0.000 title 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000006569 (C5-C6) heterocyclic group Chemical group 0.000 abstract 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000002618 bicyclic heterocycle group Chemical group 0.000 abstract 1
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 125000002950 monocyclic group Chemical group 0.000 abstract 1
- 125000002911 monocyclic heterocycle group Chemical group 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK125997 | 1997-11-05 | ||
| DKPA199800850 | 1998-06-26 | ||
| PCT/DK1998/000478 WO1999024422A1 (en) | 1997-11-05 | 1998-11-05 | Azaring-ether derivatives and their use as nicotinic ach receptor modulators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1034174T3 true DK1034174T3 (da) | 2003-09-22 |
Family
ID=26064766
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK98952578T DK1034174T3 (da) | 1997-11-05 | 1998-11-05 | Azaringetherderivater og disses anvendelse som nikotin-ACh-receptormodulatorer |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US6756386B1 (da) |
| EP (2) | EP1357121A1 (da) |
| JP (1) | JP2001522846A (da) |
| CN (1) | CN1173972C (da) |
| AT (1) | ATE247104T1 (da) |
| AU (1) | AU747419B2 (da) |
| CA (1) | CA2306477A1 (da) |
| DE (1) | DE69817214T2 (da) |
| DK (1) | DK1034174T3 (da) |
| NZ (1) | NZ503626A (da) |
| WO (1) | WO1999024422A1 (da) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69919361T2 (de) | 1998-08-25 | 2005-09-08 | Ortho-Mcneil Pharmaceutical, Inc. | Pyridyl-ether und -thioether als nikotin-acetylcholin-rezeptorliganden und ihre therapeutische anwendung |
| US6303638B1 (en) | 1999-08-06 | 2001-10-16 | The Regents Of The University Of California | Substituted pyridines as modulators of the mammalian neuronal nicotinic acetylcholine receptor |
| EP1212319A2 (en) * | 1999-09-14 | 2002-06-12 | Abbott Laboratories | 3-pyrrolidinyloxy-3'-pyridyl ether compounds useful for controlling chemical synaptic transmission |
| DE10117686A1 (de) * | 2001-04-09 | 2002-10-24 | Celanese Ventures Gmbh | Protonenleitende Membran und deren Verwendung |
| WO2003043987A2 (en) * | 2001-11-19 | 2003-05-30 | Elan Pharmaceuticals, Inc. | (4-phenyl) piperidin-3-yl-phenylcarboxylate derivatives and related compounds as beta-secretase inhibitors for the treatment of alzheimer's disease |
| WO2004113297A2 (en) * | 2003-06-24 | 2004-12-29 | Neurosearch A/S | Aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| CA2529790A1 (en) * | 2003-06-27 | 2005-01-27 | Banyu Pharmaceutical Co., Ltd. | Heteroaryloxy nitrogenous saturated heterocyclic derivative |
| WO2005123715A1 (en) * | 2004-06-18 | 2005-12-29 | Neurosearch A/S | Novel alkyl substituted piperidine derivatives as monoamine neurotransmitter re-uptake inhibitors |
| CA2580329C (en) | 2004-09-13 | 2015-01-06 | Chrono Therapeutics Inc. | Biosynchronous transdermal drug delivery |
| US20070134169A1 (en) * | 2005-12-11 | 2007-06-14 | Rabinoff Michael D | Methods for smoking cessation or alcohol cessation or other addiction cessation |
| EP2322168A1 (en) | 2007-04-02 | 2011-05-18 | Parkinson's Institute | Methods and Compositions for Reduction of Side Effects of Therapeutic Treatments |
| WO2016123406A1 (en) | 2015-01-28 | 2016-08-04 | Chrono Therapeutics Inc. | Drug delivery methods and systems |
| JP6654960B2 (ja) * | 2016-01-15 | 2020-02-26 | 日本曹達株式会社 | ルテニウム錯体の製造方法 |
| CA3049529A1 (en) | 2017-01-06 | 2018-07-12 | Chrono Therapeutics Inc. | Transdermal drug delivery devices and methods |
| AU2019279884B2 (en) | 2018-05-29 | 2025-01-30 | Morningside Venture Investments Limited | Drug delivery methods and systems |
| JP2022507660A (ja) | 2018-11-16 | 2022-01-18 | モーニングサイド ベンチャー インベストメンツ リミテッド | 温度によって調節される経皮薬剤送達システム |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR829845A (fr) | 1936-12-04 | 1938-07-07 | Delle Atel Const Electr | Coupe-circuit à basse tension à élément fusible rechargeable |
| FR2306697A1 (fr) * | 1975-04-10 | 1976-11-05 | Sogeras | Nouvelles pyrimidines utilisables comme medicaments antidiabetiques et hypocholesterolemiants |
| US4379161A (en) * | 1979-06-07 | 1983-04-05 | Michel Thominet | Novel substituted heterocyclic phenoxyamines, the method of preparation thereof and the use thereof as local anaesthetics |
| DE3227741A1 (de) * | 1982-07-24 | 1984-01-26 | Hoechst Ag, 6230 Frankfurt | 1-phenyl-isochinolinderivate und verfahren zu ihrer herstellung |
| US4592866A (en) * | 1982-09-30 | 1986-06-03 | A. H. Robins Company, Inc. | Fused aromatic oxazepinones, thiazepinones, diazepinones and sulfur analogs thereof |
| ZA848275B (en) * | 1983-12-28 | 1985-08-28 | Degussa | New piridine-2-ethers or pyridine-2-thioethers having a nitrogen-containing cycloaliphatic ring |
| US4667031A (en) * | 1985-10-15 | 1987-05-19 | Ethyl Corporation | Process for preparing oxazepinones |
| DE3835291A1 (de) * | 1988-04-19 | 1989-11-02 | Bayer Ag | 1,3-disubstituierte pyrrolidine |
| FR2640266B2 (fr) | 1988-07-12 | 1992-07-10 | Synthelabo | Derives de (hydroxy-1 piperidinyl-2 alkyl) indolones-2, quinoleinones-2, benzo(b)azepinones-2 et benzimidazolones-2, leur preparation et leur application en therapeutique |
| DE4208254A1 (de) | 1992-03-14 | 1993-09-16 | Hoechst Ag | Substituierte pyrimidine, verfahren zu ihrer herstellung und ihre verwendung als schaedlingsbekaempfungsmittel und fungizid |
| IL107184A (en) * | 1992-10-09 | 1997-08-14 | Abbott Lab | Heterocyclic ether compounds that enhance cognitive function |
| FI971334A7 (fi) * | 1994-08-03 | 1997-04-01 | Asta Medica Ag | Indoli-, indatsoli-, pyridopyrroli- ja pyridopyratsolijohdannaiset, jo illa on antiastmaattinen, antiallerginen, anti-inflammatorinen ja immu nomoduloiva vaikutus |
| GB2295387A (en) * | 1994-11-23 | 1996-05-29 | Glaxo Inc | Quinazoline antagonists of alpha 1c adrenergic receptors |
| IL118279A (en) * | 1995-06-07 | 2006-10-05 | Abbott Lab | Compounds 3 - Pyridyloxy (or Thio) Alkyl Heterocyclic Pharmaceutical Compositions Containing Them and Their Uses for Preparing Drugs to Control Synaptic Chemical Transmission |
| EP0880501A1 (en) * | 1996-02-02 | 1998-12-02 | Zeneca Limited | Heterocyclic compounds useful as pharmaceutical agents |
| US5629325A (en) * | 1996-06-06 | 1997-05-13 | Abbott Laboratories | 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission |
| DE69725113T2 (de) | 1997-02-25 | 2004-07-15 | Akzo Nobel N.V. | Azetidin- und Pyrrolidinderivate |
| DE69919361T2 (de) * | 1998-08-25 | 2005-09-08 | Ortho-Mcneil Pharmaceutical, Inc. | Pyridyl-ether und -thioether als nikotin-acetylcholin-rezeptorliganden und ihre therapeutische anwendung |
| DE19904261A1 (de) | 1999-02-03 | 2000-08-10 | Basf Ag | Verfahren zur Herstellung von Dimethylsulfit |
| RU2145680C1 (ru) | 1999-06-28 | 2000-02-20 | Открытое акционерное общество "Магистральные нефтепроводы Центральной Сибири" | Пеногенератор (варианты) |
| GB0203968D0 (en) | 2002-02-19 | 2002-04-03 | Gavon Res & Dev Ltd | Mixer |
| JP2003297848A (ja) | 2002-04-01 | 2003-10-17 | Matsushita Electric Ind Co Ltd | 半導体装置の製造方法 |
-
1998
- 1998-11-05 AT AT98952578T patent/ATE247104T1/de not_active IP Right Cessation
- 1998-11-05 AU AU10224/99A patent/AU747419B2/en not_active Ceased
- 1998-11-05 DK DK98952578T patent/DK1034174T3/da active
- 1998-11-05 NZ NZ503626A patent/NZ503626A/en unknown
- 1998-11-05 JP JP2000520436A patent/JP2001522846A/ja not_active Withdrawn
- 1998-11-05 CN CNB988106507A patent/CN1173972C/zh not_active Expired - Fee Related
- 1998-11-05 DE DE69817214T patent/DE69817214T2/de not_active Expired - Lifetime
- 1998-11-05 CA CA002306477A patent/CA2306477A1/en not_active Abandoned
- 1998-11-05 WO PCT/DK1998/000478 patent/WO1999024422A1/en not_active Ceased
- 1998-11-05 EP EP03011485A patent/EP1357121A1/en not_active Withdrawn
- 1998-11-05 EP EP98952578A patent/EP1034174B1/en not_active Expired - Lifetime
-
2000
- 2000-04-14 US US09/550,379 patent/US6756386B1/en not_active Expired - Fee Related
-
2004
- 2004-05-19 US US10/848,132 patent/US7202237B2/en not_active Expired - Fee Related
-
2007
- 2007-03-09 US US11/715,872 patent/US20070161614A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999024422A1 (en) | 1999-05-20 |
| EP1034174B1 (en) | 2003-08-13 |
| AU747419B2 (en) | 2002-05-16 |
| EP1357121A1 (en) | 2003-10-29 |
| DE69817214D1 (de) | 2003-09-18 |
| AU1022499A (en) | 1999-05-31 |
| EP1034174A1 (en) | 2000-09-13 |
| NZ503626A (en) | 2002-05-31 |
| HK1032234A1 (en) | 2001-07-13 |
| JP2001522846A (ja) | 2001-11-20 |
| US20040242558A1 (en) | 2004-12-02 |
| US6756386B1 (en) | 2004-06-29 |
| CA2306477A1 (en) | 1999-05-20 |
| DE69817214T2 (de) | 2004-06-09 |
| CN1278258A (zh) | 2000-12-27 |
| US7202237B2 (en) | 2007-04-10 |
| ATE247104T1 (de) | 2003-08-15 |
| CN1173972C (zh) | 2004-11-03 |
| US20070161614A1 (en) | 2007-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1034174T3 (da) | Azaringetherderivater og disses anvendelse som nikotin-ACh-receptormodulatorer | |
| DK0984966T3 (da) | 9-azabicyclo[3.3.1]non-2-en derivater, som er cholinerge ligander på nikotin-ACh receptorer | |
| CA2289574A1 (en) | 8-azabicyclo(3,2,1)oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ach receptors | |
| NO20060219L (no) | Forbindelser | |
| ATE254618T1 (de) | Spiro chinuclidin-derivate, ihre herstellung und verwendung | |
| ES2195933T3 (es) | Nuevos derivados de flavonas, xantonas y cumarinas. | |
| FI844333A0 (fi) | 11-substituerade 5h,11h-pyrrolo/2,1-c/ /1,4/benzoxazepiner, foerfarande foer deras framstaellning och deras anvaendning som laekemedel. | |
| DE69839753D1 (de) | 2-(Arylphenyl)amino-imidazolin-Derivate | |
| ES2073258T3 (es) | Nuevos derivados de la urea, su preparacion y su aplicacion en terapeutica. | |
| LV12824B (lv) | Fibrinogēnu receptoru antagonistu iegūšanas paņēmiens | |
| NZ221699A (en) | Pyridazinone derivatives; pharmaceutical compositions and intermediates | |
| ATE204868T1 (de) | 2-aryl-3-aminoaryloxynaphthylverbindungen, zwischenverbindungen, zusammensetzungen und verfahren | |
| NO960441L (no) | Benzopyraner og farmasöytiske forbindelser inneholdende dem | |
| DE69911176D1 (de) | Spiropiperidin-derivate | |
| DE69810107D1 (de) | Azacyclooktan- und heptan-derivate, ihre herstellung und ihre therapeutische verwendung | |
| DK0541263T3 (da) | 5-Piperazinylalkyl-1,5-benzothiazepinoner, der er nyttige som calciumantagonister | |
| ES8301480A1 (es) | Un procedimiento para la produccion de derivados de 11-piperazinil-5h--pirrolo 1,2-b, 1,2,5 benzotriazepina. | |
| DE69000806D1 (de) | Indol-derivate. | |
| ATE71367T1 (de) | Verfahren zur herstellung von indolinen. | |
| MX9202183A (es) | Ftalidas substituidas, ftalidas heterociclicas y sus derivados, proceso para su preparacion y composiciones que contienen las mismas. | |
| TH28860A (th) | สารประกอบชนิดใหม่ | |
| YU38498A (sh) | Derivati 2-(arilfenil)amino-imidazolina |